Serotonergic dysfunction and aggression control

Psychological Medicine

Volumn 21, Issue 1, 1991, Pages 15-19

  van Praag, Herman M ^a  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

5 HYDROXYINDOLEACETIC ACID; PROBENECID; SEROTONIN;

AGGRESSION; ANXIETY; EDITORIAL; HUMAN; IMPULSIVENESS; PRIORITY JOURNAL; SUICIDE;

AGGRESSION; AROUSAL; BRAIN; DEPRESSIVE DISORDER; HUMAN; RECEPTORS, SEROTONIN; SEROTONIN; SUICIDE;

EID: 0025893661     PISSN: 00332917     EISSN: 14698978     Source Type: Journal    
DOI: 10.1017/S0033291700014604     Document Type: Editorial

References (39)

1. Apter, A., van Praag, H. M., Plutchik, R., Sevy, S., Korn, M. & Brown, S.-L. (1990). Interrelationship between anxiety, aggression, impulsivity and mood. A possible serotonergically-linked cluster. Psychiatry Research (in the press).
2. Arora, R. C. & Meltzer, H. Y. (1989). Serotonergic measures in the brains of suicide victims: 5-HT2 binding sites in the frontal cortex of suicide victims and control subjects. American Journal of Psychiatry 146, 730-776.
3. Asberg, M., Traskman, L. & Thoren, P. (1976). 5-HIAA in the cerebrospinal fluid: a biochemical suicide predictor? Archives of General Psychiatry 33, 1193-1197.
4. Asberg, M., Bertilsson, L., Matensson, B., Scalia-Tombia, G.-P., Thoren, P. & Traskman, L. (1984). CSF monoamine metabolites in melancholia. Acta Psychiatrica Scandinavica 69, 201-210.
5. Charney, D. S., Wood, S. W. & Henninger, J. R. (1987). Serotonin functions in anxiety. II. Effects of the serotonin agonist MCPP in panic disorder patients and healthy subjects. Psychopharmacology 92, 14-24.
6. Coccaro, E. F., Siever, L. J., Klar, H. M., Maurer, G., Cochrane, K., Cooper, T. B., Mohs, R. C. & Davis, K. L. (1989). Serotonergic studies in patients with affective and personality disorders. Archives of General Psychiatry 46, 587-599.
7. Fishbein, D. H., Lozovsky, D. & Jaffe, J. H. (1989). Impulsivity, aggression, and neuroendocrine responses to serotonergic stimulation in substance abusers. Biological Psychiatry 25, 1049-1066.
8. Invernizzi, R., Berettera, C., Garattini, S. & Samanin, R. (1986). D-and L-isomers of fenfluramine differ markedly in their interaction with brain serotonin and catecholamines in the rat. European Journal of Pharmacology 120, 9-15.
9. Kahn, R., Wetzler, S., van Praag, H. M. & Asnis, G. M. (1988a). Behavioral indications of serotonin receptor hypersensitivity in panic disorder. Psychiatry Research 25, 101-104.
10. Kahn, R., Wetzler, S., van Praag, H. M. & Asnis, G. M. (1988b). Neuroendocrine evidence for 5-HT receptor hypersensivity in patients with panic disorder. Psychopharmacology 96, 360-364.
11. Korn, M., Brown, S.-L. & van Praag, H. M. (1989). Serotonergic disturbances in suicide. Paper read at the World Congress of Psychiatry, Athens (in the press).
12. Korn, M. L., Kotler, M., Molcho, A., Grosz, D., Brown, S.-L., Chen, C. & van Praag, H. M. (1990). Suicide and aggression associated with panic attacks. Biological Psychiatry (submitted).
13. Linnoila, M., Virkhunen, M., Scheinin, M., Nuutila, A., Rimon, R. & Goodwin, F. K. (1983). Low cerebrospinal fluid 5-hydroxyindoleacelic acid concentration differentiates impulsive from non-impulsive violent behavior. Life Sciences 33, 2609-2614.
14. Mann, J. J., Stanley, M., McBride, A. & McEwen, B. S. (1986). Increased serotonin3 and β-adrenergic receptor binding in the frontal cortices of suicide victims. Archives of General Psychiatry 43. 954-959
15. Mellzer. H. Y., Perline, R., Tricou. B. J., Lowy. M. T. & Robertson. A. (1984). Effect of 5-hydroxylryptophan on serum Cortisol levels in major affective disorders. II. Relations to suicide, psychosis, and depressive symptoms. Archives of General Psychiatry 41. 379-387.
16. Morand, C., Young, J. N. & Ervin. F. R. (1983). Clinical response of aggressive schizophrenics to oral tryptophan. Biological Psychiatry 18. 575-578.
17. Ninan. P. T., van Kammen. D. P., Scheinin, M., Linnoila, M., Bunney. W. E.&Goodwin. F. K.(1984).CSF5-hydroxyindoleacetic acid levels in suicidal schizophrenic patients. American Journal of Psychiatry 141, 566-569.
18. Olivier. B., van Dalen, D. & Hartog, J. (1986). A new class of psychotropic drugs: serenics. Drugs of the Future 11, 473-494.
19. Plulehik. R., van Praag, H. M. & Conte. H. R. (1989a). Correlates of suicide and violence risk. III. A two-stage model of countervailing forces. Psychiatry Research 28. 215 225.
20. Plulehik. R., van Praag, H. M., Picard. S., Conte. H. R. & Korn. M. (1989/)). Is there a relation between seriousness of suicide intent and Ihe lethality of the suicide attempt? Psychiatry Research 27, 71-79.
21. Roy, A., & Linnoila, M. (1988). Suicidal behavior, impulsiveness and serotonin. Acta Psychiatrica Scantlinavica 78. 529 535.
22. Roy. A., Adinoff. B. & Linnoila. M. (1988). Acting out hostility in normal volunteers: negative correlation with levels of 5-HIAA in cerebral spinal Fluid. Psychiatry Research 24, 187-194.
23. Roy. A., Adinoff, B., Roehrich, L., Lamparski, D., Custer, R., Lorenj, V., Barbaccia, M., Guidotti. A., Costa, E. & Linnoila. M. (1988). Pathological gambling. Archives of General Psychiatry 45, 369-373.
24. Roy. A., DeJong, J. & Linnoila, M. (1989). Cerebrospinal Fluid monoamine metabolites and suicidal behavior in depressed patients. Archives of General Psychiatry 46, 609-612.
25. Soubrie. P. (1986). Reconciling the role of central serotonin neurons in human and animal behavior. Behavioral and Brain Sciences 9, 319-363.
26. Traskman. L., Asberg, M., Bertilsson, L. & Sjostrand, L. (1981). Monoamine metabolites in CSF and suicidal behavior. Archives of General Psychiatry 38, 631-636.
27. van Praag, H. M. (1982). Depression, suicide and the metabolism of serotonin in the brain. Journal of Affective Disorders 4, 275-290.
28. van Praag, H. M. (1983). CSF 5-HIAA and suicide in non-depressed schizophrenics. Lancet i, 977-978.
29. van Praag, H. M. (1986a). (Auto)aggrcssion and CSF 5-HIAA in depression and schizophrenia. Psychopharinacology Bulletin 22, 669-673.
30. van Praag, H. M. (1986b). Biological suicide research: outcome and limitations. Biological Psychiatry 21, 1305-1323.
31. van Praag, H. M. (1988). Serotonergic mechanisms and suicidal behaviour. Psychiatry anil Psychohiology 3, 335-346.
32. van Praag, H. M. & Korf, J. (1971). Endogenous depressions with and without disturbances in the 5-hydroxytryptamine metabolism: a biochemical classification? Psychopharmacologia 19, 148-152.
33. van Praag, H. M. & Plutchik, R. (1985). An empirical study on the “cathartic effect’ of attempted suicide. Psychiatry Research 16, 123-130.
34. van Praag, H. M., Ulemann, A. M. & Spitz, J. C. (1965). The vital syndrome interview. A structured standard interview for the recognition and registration of the vital depression symptom complex. Psychiatrica Neurologia Neurochirurgia 68, 329-346.
35. van Praag, H. M., Korf, J. & Puite, J. (1970). 5-hydroxyindoleacetic acid levels in the cerebrospinal fluid of depressive patients treated with probenecid. Nature 225, 1259-1260.
36. Virkkunen, M., Nultila, A., Goodwin, F. K. & Linnoila, M. (1987). Cerebrospinal fluid monoamine metabolite levels in male arsonists. Archives of General Psychiatry 44, 241-247.
37. Virkkunen, M., DeJong, J., Bartko, J. & Linnoila, M. (1989). Psychobiological concomitants of history of suicide attempts among violent offenders and impulsive fire setters. Archives of General Psychiatry 46, 604-606.
38. Volavka, J., Crowner, M., Brizer, D., Convit, A., van Praag, H. M. & Cooper, T. (1990). Tryptophan treatment of aggressive psychiatric patients. Biological Psychiatry (in the press).
39. Weissman, M. M., Klerman, G. L., Markowilz, J. S. & Ouellelte, R. (1989). Suicidal ideation and suicide attempt in panic disorder and attacks. New England Journal of Medicine 321, 1209-1214.